DE69637325D1 - Methode für die behandlung einer hepatitisvirusinfektion - Google Patents

Methode für die behandlung einer hepatitisvirusinfektion

Info

Publication number
DE69637325D1
DE69637325D1 DE69637325T DE69637325T DE69637325D1 DE 69637325 D1 DE69637325 D1 DE 69637325D1 DE 69637325 T DE69637325 T DE 69637325T DE 69637325 T DE69637325 T DE 69637325T DE 69637325 D1 DE69637325 D1 DE 69637325D1
Authority
DE
Germany
Prior art keywords
treatment
virus infection
hepatitis virus
hepatitis
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637325T
Other languages
English (en)
Inventor
Hiroshi Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE69637325D1 publication Critical patent/DE69637325D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0271Chimeric vertebrates, e.g. comprising exogenous cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69637325T 1995-09-27 1996-09-27 Methode für die behandlung einer hepatitisvirusinfektion Expired - Lifetime DE69637325D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US435795P 1995-09-27 1995-09-27
PCT/US1996/015554 WO1997011598A1 (en) 1995-09-27 1996-09-27 Method for treating hepatitis virus infection

Publications (1)

Publication Number Publication Date
DE69637325D1 true DE69637325D1 (de) 2007-12-27

Family

ID=21710385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637325T Expired - Lifetime DE69637325D1 (de) 1995-09-27 1996-09-27 Methode für die behandlung einer hepatitisvirusinfektion

Country Status (6)

Country Link
EP (1) EP0866654B1 (de)
JP (1) JP2000501921A (de)
AT (1) ATE377944T1 (de)
AU (1) AU7377296A (de)
DE (1) DE69637325D1 (de)
WO (1) WO1997011598A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296844B1 (en) * 1995-09-27 2001-10-02 The General Hospital Corporation Asialocytokines and treatment of liver disease
AU6092900A (en) * 1999-07-14 2001-02-05 Board Of Trustees Of The Leland Stanford Junior University Animals comprising human hepatocellular tissue
US20040101827A1 (en) * 2000-10-03 2004-05-27 Michinori Kohara Methods of infection with hepatitis c virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950014915B1 (ko) * 1991-06-19 1995-12-18 주식회사녹십자 탈시알로당단백-포함화합물
CA2161798C (en) * 1993-05-17 2005-04-05 Yair Reisner Animal model for hepatitis virus infection
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome

Also Published As

Publication number Publication date
EP0866654B1 (de) 2007-11-14
AU7377296A (en) 1997-04-17
EP0866654A4 (de) 2002-08-21
ATE377944T1 (de) 2007-11-15
WO1997011598A1 (en) 1997-04-03
JP2000501921A (ja) 2000-02-22
EP0866654A1 (de) 1998-09-30

Similar Documents

Publication Publication Date Title
DE69112480T2 (de) Verfahren und Vorrichtung zur Behandlung von medizinischen Abfallstoffen.
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
DE3789158T2 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
ATE206757T1 (de) Thrombin sowie verfahren zu seiner herstellung
DE69226991D1 (de) Verfahren und Vorrichtung zur Behandlung von infektiösen medizinischen Abfällen
DE3784753D1 (de) Vorrichtung und verfahren zur behandlung stehender gewaesser.
ATA108689A (de) Vorrichtung und verfahren zur behandlung von medizinischen sonderabfällen
DE69423164T2 (de) Verfahren und Vorrichtung zur biologischen Aufbereitung von wässerigen organischen Abfällen
DE59009072D1 (de) Verfahren und vorrichtung zur ermittlung von chemischen zuständen von lebendem, tierischem oder menschlichem gewebe unter verwendung von magnetischer resonanz.
DE69013880D1 (de) Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
DE3874579D1 (de) Verfahren und vorrichtung zur behandlung von tierischem fleisch, insbesondere von fisch, zum entfaerben und geruchlosmachen.
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69637325D1 (de) Methode für die behandlung einer hepatitisvirusinfektion
DE69012808D1 (de) Vorrichtung zur behandlung von lebenden fischen und fischbrut und deren verwendung.
DE69112909D1 (de) Verfahren und Vorrichtung zur Kultivierung von anaeroben Keimen.
DE3873744T2 (de) Vorrichtung and verfahren zur sterilisation.
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE3877059T2 (de) Verfahren zur behandlung von abgasen durch strahlung und vorrichtung dafuer.
DE59609871D1 (de) Vorrichtung zur verbesserten handhabung von führungsdrähten insbesondere bei katheteruntersuchungen
DE69011044D1 (de) Verfahren und Vorrichtung zur Behandlung von Abgas.
DE69006509D1 (de) Verfahren zur behandlung von häuten.
DE69008690D1 (de) Verfahren und Vorrichtung zur Bestimmung von aeroben Bakterien.
DE3674213D1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.

Legal Events

Date Code Title Description
8332 No legal effect for de